Gliclazide D4
| Product Name | Gliclazide D4 |
|---|---|
| Alternate Names | Gliclazide Stable Isotopes, Stable Isotopes of Gliclazide |
| CAT No. | CS-O-03063 |
| CAS No. | 1185039-30-8 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 327.44 g/mol |
| Mol. For. | C₁₅H₁₇D₄N₃O₃S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Gliclazide |
| Purity | Not less than 95% |
| Therapeutic | Anti-Diabetic |
| Smileys | O=C(N[S](=O)(C(C([2H])=C1[2H])=C(C([2H])=C1C)[2H])=O)NN2CC(CCC3)C3C2 |
| Canonical Smiles | CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2 |
| InchIKey | BOVGTQGAOIONJV-KDWZCNHSSA-N |
| Inchl | InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/i5D,6D,7D,8D |
| IUPAC | 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(2,3,5,6-tetradeuterio-4-methylphenyl)sulfonylurea |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Gliclazide D4 is a deuterated form of the oral anti-diabetic medication, Gliclazide. It is used in the treatment of type 2 diabetes mellitus, a condition that arises due to the body's inability to produce or effectively use insulin. Gliclazide D4 is specifically designed for use in research studies, including pharmacokinetic and pharmacodynamic studies, where the use of deuterated compounds is necessary for accurate analysis.
The chemical formula for Gliclazide D4 is C15H9D4N3O3S, and it has a molecular weight of 329.43 g/mol. The deuterated form of Gliclazide is created by replacing four hydrogen atoms with deuterium atoms, which are isotopes of hydrogen with a slightly higher mass. This modification does not change the therapeutic effects or mechanism of action of the medication, but it does allow for more precise determination of drug concentrations in biological samples.
Gliclazide D4 works by stimulating the pancreas to release insulin, which helps to lower blood sugar levels. It does this by binding to specific receptors on the beta cells of the pancreas, which triggers the release of insulin. Gliclazide D4 is typically administered orally, and its effects can last for up to 24 hours.
In conclusion, Gliclazide D4 is a deuterated form of the oral anti-diabetic medication, Gliclazide, which is used in research studies for accurate analysis. Its chemical formula is C15H9D4N3O3S, and it works by stimulating the pancreas to release insulin. Gliclazide D4 is a valuable tool for researchers studying the pharmacokinetics and pharmacodynamics of anti-diabetic medications.
Get an Instant Quote
Related Compounds
Hydroxy Gliclazide-d4 | Carboxy Gliclazide-d4 |